Envestnet Asset Management Inc. Reduces Stock Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Envestnet Asset Management Inc. lowered its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) by 3.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 69,753 shares of the company’s stock after selling 2,507 shares during the period. Envestnet Asset Management Inc. owned about 0.08% of Pediatrix Medical Group worth $1,037,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Smith Graham & Co. Investment Advisors LP lifted its stake in Pediatrix Medical Group by 17.0% in the fourth quarter. Smith Graham & Co. Investment Advisors LP now owns 372,847 shares of the company’s stock worth $5,541,000 after acquiring an additional 54,256 shares during the period. ProShare Advisors LLC increased its position in shares of Pediatrix Medical Group by 12.7% during the fourth quarter. ProShare Advisors LLC now owns 12,914 shares of the company’s stock valued at $192,000 after buying an additional 1,460 shares during the period. New York State Common Retirement Fund increased its position in shares of Pediatrix Medical Group by 1.9% during the fourth quarter. New York State Common Retirement Fund now owns 1,554,888 shares of the company’s stock valued at $23,106,000 after buying an additional 29,019 shares during the period. Foundry Partners LLC boosted its holdings in shares of Pediatrix Medical Group by 25.5% during the 4th quarter. Foundry Partners LLC now owns 208,734 shares of the company’s stock valued at $3,102,000 after buying an additional 42,386 shares in the last quarter. Finally, Marshall & Sullivan Inc. WA bought a new stake in Pediatrix Medical Group during the fourth quarter worth about $43,000. Hedge funds and other institutional investors own 95.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on MD shares. Truist Financial decreased their price objective on shares of Pediatrix Medical Group from $17.00 to $15.00 in a report on Tuesday, May 9th. Credit Suisse Group reduced their price target on shares of Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating for the company in a research report on Wednesday, February 22nd. StockNews.com assumed coverage on Pediatrix Medical Group in a research report on Thursday, May 18th. They issued a “hold” rating for the company. Mizuho lowered their price target on shares of Pediatrix Medical Group from $17.00 to $15.00 in a report on Wednesday, May 3rd. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of Pediatrix Medical Group from $15.50 to $14.00 in a report on Wednesday, May 3rd. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $17.67.

Insider Activity at Pediatrix Medical Group

In other news, Director Shirley A. Weis sold 17,993 shares of Pediatrix Medical Group stock in a transaction on Thursday, May 18th. The stock was sold at an average price of $13.55, for a total value of $243,805.15. Following the transaction, the director now directly owns 18,675 shares in the company, valued at approximately $253,046.25. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.00% of the stock is owned by company insiders.

Pediatrix Medical Group Stock Performance

Pediatrix Medical Group stock opened at $13.27 on Friday. The firm has a market capitalization of $1.11 billion, a P/E ratio of 10.88, a price-to-earnings-growth ratio of 0.60 and a beta of 1.74. Pediatrix Medical Group, Inc. has a 1-year low of $12.84 and a 1-year high of $23.95. The company’s 50-day moving average is $14.24 and its 200 day moving average is $14.98. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.44 and a quick ratio of 1.44.

Pediatrix Medical Group Company Profile

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.